Education
About Us
Working with TipRanks
Follow Us
Universal Health (UHS)
NYSE:UHS
UHS Analyst Ratings
Moderate Buy
6 Buy
4 Hold
1 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
UHS Stock 12 Month Forecast
Average Price Target
$223.67
▲(32.40%Upside)
| Highest Price Target$280.00 | Average Price Target$223.67 | Lowest Price Target$185.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
TipRanks
$197
Buy
16.61%
Upside
Reiterated
07/16/25
TD Cowen
$226
Buy
33.78%
Upside
Reiterated
07/21/25
We estimate softer Behavioral volumes in 2Q25 and beyond, and a slightly larger drag from a slower ramp at UHS' new DC hospital Cedar Hills that opened during 2Q25. The combination of these factors get us to $600m in adj EBITDA vs our prior estimate of $620m and consensus $616m. We raise our 2H25 estimates due primarily to the recently approved Program (total in and out of period amount of +$76m). Stronger contribution from UHS' new NV West Henderson hospital, per management commentary this facility is ramping faster than historical averages and may ultimately offset to the Cedar Hills drag. Our FY25 adj EBITDA-NCI estimate moves +1% to $2.45b (from $2.43b) but our FY26 adj EBITDA-NCI estimate at $2.61b is largely unchanged. We maintain our $226 PT based on 7.5x 2026E EV/EBITDA-NCI.
Bank of America Securities
$215→$185
Sell
9.51%
Upside
Downgraded
07/16/25
RBC Capital
$201
Hold
18.98%
Upside
Reiterated
07/14/25
Barclays
$257
Buy
52.13%
Upside
Reiterated
07/10/25
Leerink Partners
―
Buy
―
Reiterated
07/04/25
Cantor Fitzgerald
$227
Hold
34.37%
Upside
Reiterated
07/02/25
Morgan Stanley
$200
Hold
18.39%
Upside
Reiterated
06/04/25
Wells Fargo
$225
Buy
33.18%
Upside
Reiterated
05/29/25
Guggenheim
$208→$212
Buy
25.49%
Upside
Reiterated
04/30/25
KeyBanc
―
Hold
―
Reiterated
04/30/25
Robert W. Baird
$274→$224
Hold
32.59%
Upside
Downgraded
04/14/25
J.P. Morgan
$215
Hold
27.26%
Upside
Reiterated
03/14/25
Stephens
$223
Hold
32.00%
Upside
Reiterated
02/27/25
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TipRanks
$197
Buy
16.61%
Upside
Reiterated
07/16/25
TD Cowen
$226
Buy
33.78%
Upside
Reiterated
07/21/25
We estimate softer Behavioral volumes in 2Q25 and beyond, and a slightly larger drag from a slower ramp at UHS' new DC hospital Cedar Hills that opened during 2Q25. The combination of these factors get us to $600m in adj EBITDA vs our prior estimate of $620m and consensus $616m. We raise our 2H25 estimates due primarily to the recently approved Program (total in and out of period amount of +$76m). Stronger contribution from UHS' new NV West Henderson hospital, per management commentary this facility is ramping faster than historical averages and may ultimately offset to the Cedar Hills drag. Our FY25 adj EBITDA-NCI estimate moves +1% to $2.45b (from $2.43b) but our FY26 adj EBITDA-NCI estimate at $2.61b is largely unchanged. We maintain our $226 PT based on 7.5x 2026E EV/EBITDA-NCI.
Bank of America Securities
$215→$185
Sell
9.51%
Upside
Downgraded
07/16/25
RBC Capital
$201
Hold
18.98%
Upside
Reiterated
07/14/25
Barclays
$257
Buy
52.13%
Upside
Reiterated
07/10/25
Leerink Partners
―
Buy
―
Reiterated
07/04/25
Cantor Fitzgerald
$227
Hold
34.37%
Upside
Reiterated
07/02/25
Morgan Stanley
$200
Hold
18.39%
Upside
Reiterated
06/04/25
Wells Fargo
$225
Buy
33.18%
Upside
Reiterated
05/29/25
Guggenheim
$208→$212
Buy
25.49%
Upside
Reiterated
04/30/25
KeyBanc
―
Hold
―
Reiterated
04/30/25
Robert W. Baird
$274→$224
Hold
32.59%
Upside
Downgraded
04/14/25
J.P. Morgan
$215
Hold
27.26%
Upside
Reiterated
03/14/25
Stephens
$223
Hold
32.00%
Upside
Reiterated
02/27/25
Best Analysts Covering Universal Health
1 Month
xxx
Success Rate
16/23 ratings generated profit
Average Return
+1.24%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 69.57% of your transactions generating a profit, with an average return of +1.24% per trade.
3 Months
xxx
Success Rate
17/28 ratings generated profit
Average Return
+2.04%
reiterated a xxx
rating 18 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 60.71% of your transactions generating a profit, with an average return of +2.04% per trade.
1 Year
2 Years
xxx
Success Rate
20/29 ratings generated profit
Average Return
+19.55%
reiterated a xxx
rating 12 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 68.97% of your transactions generating a profit, with an average return of +19.55% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
UHS Analyst Recommendation Trends
Rating
Mar 25
Apr 25
May 25
Jun 25
Jul 25
Strong Buy
0
0
0
1
1
Buy
6
12
10
14
12
Hold
6
13
11
10
5
Sell
0
0
0
0
1
Strong Sell
0
0
0
0
0
total
12
25
21
25
19
Each month's total comprises the sum of three months' worth of ratings.
UHS Financial Forecast
UHS Stock Forecast FAQ
What is UHS’s average 12-month price target, according to analysts?
Based on analyst ratings, Universal Health’s 12-month average price target is 223.67.
What is UHS’s upside potential, based on the analysts’ average price target?
Universal Health has 32.40% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is UHS a Buy, Sell or Hold?
Universal Health has a consensus rating of Moderate Buy which is based on 6 buy ratings, 4 hold ratings and 1 sell ratings.
What is Universal Health’s price target?
The average price target for Universal Health is 223.67. This is based on 11 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $280.00 ,the lowest forecast is $185.00. The average price target represents 32.40% Increase from the current price of $168.94.
The highest analyst price target is $280.00 ,the lowest forecast is $185.00. The average price target represents 32.40% Increase from the current price of $168.94.
What do analysts say about Universal Health?
Universal Health’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 11 Wall Streets Analysts.
How can I buy shares of UHS?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.